mequitazine
Also known as Kitazemin, Mequitazina, Mequitazinum
Mequitazine (trade name Primalan) is an H1 antagonist and anticholinergic of the phenothiazine chemical class. It is used to treat allergies and rhinitis.
Research
153 papers- Development of radioiodine-labeled mequitazine for evaluation of hepatic CYP2D activity.Frontiers in pharmacology · 2024
- [Efficiency of mequitazine in the treatment of allergic rhinitis and chronic urticaria in children. A bibliographic systematic review].Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) · 2008
- Second-Generation H(1)-Receptor Antagonists, Mequitazine, Azelastine and Desloratadine Activate Caspase-8, Caspase-3, and Gasdermin E and Induce Cell Death Showing Pyroptotic-Like Features in Macrophages at Excessively High Concentrations.Biological & pharmaceutical bulletin · 2025
- Photodegradation and photostability-indication of mequitazine.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2009
- Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes.The Journal of pharmacology and experimental therapeutics · 1998
via PubMed
Article
8 sectionsContents
- Contraindications
- Special precautions
- Adverse reactions
- Drug interactions
- Synthesis
- References
- Further reading
- External links
Mequitazine (trade name Primalan) is an H1 antagonist and anticholinergic of the phenothiazine chemical class. It is used to treat allergies and rhinitis.
It was patented in 1969 and came into medical use in 1976.
Available in 10 languages
via Wikidata sitelinks · CC0
Connections
Categories
Cleanup tagged articles with a reason field from March 2021Drugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs with non-standard legal statusECHA InfoCard ID from WikidataH1 receptor antagonistsM1 receptor antagonistsM2 receptor antagonistsM3 receptor antagonistsM4 receptor antagonistsM5 receptor antagonists